Professor Robert Storey

BSc, BM, DM, FRCP, FESC

Department of Infection, Immunity and Cardiovascular Disease

Professor of Cardiology

r.f.storey@sheffield.ac.uk
+44 114 215 9554

Full contact details

Professor Robert Storey
Department of Infection, Immunity and Cardiovascular Disease
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

I joined the University of Sheffield in 2002 as a Senior Clinical Lecturer in Cardiology and subsequently became Professor of Cardiology in January 2011. I am Clinical Lead for the Cardiovascular Disease research theme and Director of the Cardiovascular Research Unit. I am also Academic Director for the Cardiology and Cardiothoracic Surgery Directorate and an Honorary Consultant Cardiologist with Sheffield Teaching Hospitals National Health Service Foundation Trust.

I have a special interest in atherothrombosis and antithrombotic therapy in the management of ischaemic heart disease, including coronary intervention. I was Chair of the European Society of Cardiology (ESC) Working Group on Thrombosis 2012-2014 and have been a member of 4 Task Forces for ESC Guidelines as well as author of many ESC position papers. I received a BSc Hons in biochemistry from the University of York, UK, in 1985 before going on to obtain my medical degree (BM) from the University of Southampton in 1989. After completing general professional training, I trained in the fields of Cardiology and General (Internal) Medicine at Queen´s Medical Centre in Nottingham, completing specialist training in both fields in 2001.

During that time, I developed a keen interest in thrombosis research, studying platelet biology and pharmacology, conducting clinical research studies in patients with cardiovascular disease and obtaining a postgraduate degree in research (DM) from the University of Nottingham.

I have been an Executive/Steering Committee member of numerous international clinical trials such as the PLATO, PEGASUS-TIMI 54, AUGUSTUS and COMPLETE studies and am currently a member of the steering committees for the RAPID-CTCA, SENIOR-RITA, CLEAR-SYNERGY and other studies.

Research interests

My principal research area is atherothrombosis. My particular interests are:

  • platelet pharmacology
  • relationships between inflammation and atherothrombosis
  • fibrin clot properties and thrombotic risk
  • cardiovascular clinical trials
  • clinical practice guidelines

Current projects

Numerous projects in the areas of antithrombotic therapy and acute coronary syndromes.

Publications

Show: Featured publications All publications

Journal articles

All publications

Journal articles

Chapters

  • Parker W & Storey R (2018) Acute coronary syndromes: Thrombotic Response RIS download Bibtex download
  • Thomas MR & Storey RF (2017) Platelets in Acute Coronary Syndromes, Platelets in Thrombotic and Non-Thrombotic Disorders (pp. 1015-1028). Springer International Publishing RIS download Bibtex download
  • Jackman LE & Storey RF (2009) Prasugrel In Editors-in-Chief:  S.J. Enna & David B. Bylund (Ed.), xPharm: The Comprehensive Pharmacology Reference (pp. 1-4). New York: Elsevier. RIS download Bibtex download
  • Jackman LE & Storey RF (2009) MRS 2395 In Editors-in-Chief:  S.J. Enna & David B. Bylund (Ed.), xPharm: The Comprehensive Pharmacology Reference (pp. 1-2). New York: Elsevier. RIS download Bibtex download

Conference proceedings papers

  • Tomaniak M, Chichareon P, Takahashi K, Kogame N, Modolo R, Chang CC, Katagiri Y, Cano ES, Neumann F-J, Plante S , Antolin RH et al (2019) LONG-TERM SAFETY OF TICAGRELOR MONOTHERAPY IN PATIENTS UNDERGOING PCI FOR STABLE CORONARY ARTERY DISEASE IN THE GLOBAL LEADERS STUDY: IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Journal of the American College of Cardiology, Vol. 73(9) (pp 196-196) RIS download Bibtex download
  • Iqbal A, Prince L, Novodvorsky P, Bernjak A, Thomas M, Birch L, Lambert D, Kay L, Wright F, Jacques R , Storey R et al (2018) Acute hypoglycaemia results in increased activation of responses to an inflammatory challenge induced 48 hours later in human subjects. DIABETOLOGIA, Vol. 61 (pp S446-S446) RIS download Bibtex download
  • Lindholm D, James S, Gabrysch K, Storey RF, Himmelmann A, Cannon CP, Mahaffey KW, Steg PG, Held C, Siegbahn A , Wallentin L et al (2018) Multiple biomarkers and cause-specific mortality in patients with acute coronary syndromes - Insights from the PLATO biomarker substudy. EUROPEAN HEART JOURNAL, Vol. 39 (pp 145-146) RIS download Bibtex download
  • Sumaya W, Wallentin L, James SK, Siegbahn A, Gabrysch K, Himmelmann A, Ajjan RA & Storey RF (2018) Impaired fibrin clot lysis persists at 1 month post ACS: a PLATO substudy. EUROPEAN HEART JOURNAL, Vol. 39 (pp 882-883) RIS download Bibtex download
  • Sumaya W, Wallentin L, James SK, Siegbahn A, Gabrysch K, Bertilsson M, Himmelmann A, Ajjan R & Storey RF (2018) Adverse Fibrin Clot Properties Are Associated With Worse Outcome Following Acute Coronary Syndrome: A PLATO Substudy. CIRCULATION, Vol. 136 View this article in WRRO RIS download Bibtex download
  • Geisler T, Muenzer P, Alnaggar N, Geue S, Tegtmeyer R, Rath D, Droppa M, Seizer P, Heitmeier S, Heemskerk JWM , Jennings L et al (2018) INHIBITORY MECHANISMS OF VERY LOW DOSE RIVAROXABAN IN NON-ST-ELEVATION MYOCARDIAL INFARCTION. Journal of the American College of Cardiology, Vol. 71(11) (pp A1398-A1398) RIS download Bibtex download
  • Parker W, Orme RC, Sumaya W, Hanson J, Stokes H, McMellon H, Shaw P, Judge H & Storey R (2018) ULTRA-LOW-DOSE TWICE-DAILY ASPIRIN IMPROVES HEMOSTASIS AND MAINTAINS PLATELET INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS RECEIVING TICAGRELOR. Journal of the American College of Cardiology, Vol. 71(11) (pp A30-A30) RIS download Bibtex download
  • Iqbal A, Thomas M, Novodvorsky P, Bernjak A, Birch L, Lambert D, Kay L, Wright F, Prince L, Francis S , Storey R et al (2017) Hypoglycaemia increases platelet reactivity and promotes formation of proatherogenic platelet-leucocyte aggregates. DIABETOLOGIA, Vol. 60 (pp S532-S532) RIS download Bibtex download
  • Bonaca M, Jarolim P, Goodrich EL, Storey RF, Bhatt DL, Steg PG, Cohen M, Jensen E, Johanson R, Braunwald E , Morrow DA et al (2017) Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. EUROPEAN HEART JOURNAL, Vol. 38 (pp 612-612) RIS download Bibtex download
  • Iqbal A, Thomas M, Novodvorsky P, Bernjak A, Birch L, Lambert D, Kay L, Wright F, Prince L, Francis S , Storey R et al (2017) Effect of Hypoglycemia on Platelet Reactivity and Platelet-Leukocyte Kinetics. DIABETES, Vol. 66 (pp A41-A41) RIS download Bibtex download
  • Weng Ow K, Thomas M, Parker W, Judge H & Storey R (2017) 72 Offset of ticagrelor prior to coronary artery bypass graft surgery (cabg) surgery. Heart, Vol. 103(Suppl 5) (pp A53.2-A54) RIS download Bibtex download
  • Gosling R, Yazdani M, Parviz Y, Hall I, Grech E, Gunn J, Storey R & Iqbal J (2017) COMPARISON OF P2Y12 INHIBITORS FOR MORTALITY AND STENT THROMBOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES: SINGLE CENTRE STUDY OF 10,793 CONSECUTIVE ‘REAL-WORLD’ PATIENTS. Journal of the American College of Cardiology, Vol. 69(11) (pp 1014-1014) RIS download Bibtex download
  • Ueland T, Akerblom A, Ghukasyan T, Michelsen AE, Aukrust P, Becker RC, Bertilsson M, Himmelmann A, James SK, Siegbahn A , Storey RF et al (2016) Osteoprotegerin is Associated With Major Bleeding but Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes - Insights From the PLATelet Inhibition and Patient Outcomes (PLATO) Trial. CIRCULATION, Vol. 134 RIS download Bibtex download
  • Ueland T, Akerblom A, Ghukasyan T, Michelsen AE, Aukrust P, Becker RC, Bertilsson M, Himmelmann A, James SK, Siegbahn A , Storey RF et al (2016) Osteoprotegerin is Associated With Major Bleeding but Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes - Insights From the PLATelet Inhibition and Patient Outcomes (PLATO) Trial. CIRCULATION, Vol. 134 RIS download Bibtex download
  • Van't Hof A, Fabris E, Giannini F, Johanne S, Rousseau E, Vicaut E, Cequier A, Tsatsaris A, Huber K, Hamm C , Janzon M et al (2016) Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: the ATLANTIC ST-segment resolution substudy. EUROPEAN HEART JOURNAL, Vol. 37 (pp 1173-1173) RIS download Bibtex download
  • Franchi F, Angiolillo DJ, Ghukasyan T, Budaj A, Cornel JH, Husted S, Katus HA, Keltai M, Kontny F, Lewis BS , Storey RF et al (2016) Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y12 receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial. EUROPEAN HEART JOURNAL, Vol. 37 (pp 1224-1224) RIS download Bibtex download
  • Cavallari I, Aylward P, Steg PG, Storey RF, Bhatt DL, Cohen M, Budaj A, Corbalan R, Theroux P, Lopez-Sendon J , Isaza D et al (2016) Potential role of ticagrelor in preventing venous and cardiac thrombosis: insights from PEGASUS-TIMI 54. EUROPEAN HEART JOURNAL, Vol. 37 (pp 636-637) RIS download Bibtex download
  • Varenhorst CV, Akerblom A, Renlund H, Kunadian V, James SK, Steg PG, Katus HA, Himmelmann A, Aylward P, Maurer G , Storey RF et al (2016) Successful reperfusion is associated with lower levels of markers of myocardial damage and dysfunction in ST-elevation but not in non-ST-elevation myocardial infarction: insights from the PLATO trial. EUROPEAN HEART JOURNAL, Vol. 37 (pp 1282-1283) RIS download Bibtex download
  • Thomas MR, Iqbal A, Outteridge SN, Judge HM, Dockrell DH, Sabroe I & Storey RF (2016) Platelet P2Y12 inhibitors enhance expansion of the intermediate monocyte population following systemic inflammation in humans. EUROPEAN HEART JOURNAL, Vol. 37 (pp 904-904) RIS download Bibtex download
  • Horne A, Gunn J, Iqbal J, Morgan K, Hall I, West J, Grech E, Barmby D, Wheeldon N, Storey R & Richardson J (2016) 27 Impact of Culprit Versus Non-Culprit Angiography Strategy on Primary PCI Door to Balloon Times. Heart, Vol. 102(Suppl 6) (pp A18-A18) RIS download Bibtex download
  • Lindholm D, Lindbäck J, James S, Becker R, Cornel J, Himmelmann A, Giannitsis E, Harrington R, Held C, Husted S , Katus H et al (2016) PREDICTION OF MAJOR BLEEDING IN REVASCULARIZED PATIENTS WITH ACUTE CORONARY SYNDROMES: DEVELOPMENT OF A NOVEL BIOMARKER-BASED CLINICAL PREDICTION MODEL. Journal of the American College of Cardiology, Vol. 67(13) (pp 493-493) RIS download Bibtex download
  • Bansilal S, Bonaca M, Cornel JH, Storey R, Bhatt D, Steg P, Im K, Held P, Jensen E, Braunwald E , Sabatine M et al (2016) EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL. Journal of the American College of Cardiology, Vol. 67(13) (pp 2146-2146) RIS download Bibtex download
  • Bhatt DL, Bonaca M, Bansilal S, Cohen M, Storey RF, Im K, Murphy S, Held P, Braunwald E, Sabatine M & Steg PG (2016) REDUCTION IN ISCHEMIC EVENTS WITH TICAGRELOR IN DIABETIC PATIENTS FROM THE PEGASUS-TIMI 54 TRIAL. Journal of the American College of Cardiology, Vol. 67(13) (pp 2111-2111) RIS download Bibtex download
  • Åkerblom A, James S, Bertilsson M, Himmelmann A, Huhn M, Pieper K, Husted S, Storey R, Becker R & Wallentin L (2016) SERUM URIC ACID IS ASSOCIATED WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES: RESULTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 67(13) (pp 556-556) RIS download Bibtex download
  • Bonaca MP, Bhatt D, Storey R, Steg P, Cohen M, Kuder J, Im K, Held P, Jensen E, Braunwald E & Sabatine M (2016) EFFICACY AND SAFETY OF TICAGRELOR AS LONG-TERM SECONDARY PREVENTION IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION AND PERIPHERAL ARTERY DISEASE. Journal of the American College of Cardiology, Vol. 67(13) (pp 2266-2266) RIS download Bibtex download
  • Bonaca MP, Bhatt DL, Ophuis TO, Steg PG, Storey R, Cohen M, Kuder J, Im K, Magnani G, Budaj A , Theroux P et al (2015) Long-Term Tolerability of Ticagrelor in the PEGASUS-TIMI 54 Trial. CIRCULATION, Vol. 132(23) (pp 2272-2272) RIS download Bibtex download
  • Bonaca MP, Storey RF, Theroux P, Steg PG, Bhatt DL, Im K, Magnani G, Ophuis TO, Ruda M, Parkhomenko A , Isaza D et al (2015) Consistent Benefit of Ticagrelor Both Early and Late in Patients With Prior MI in PEGASUS-TIMI 54. CIRCULATION, Vol. 132 RIS download Bibtex download
  • Lindholm D, Hagstrom E, James SK, Becker RC, Cannon CP, Himmelmann A, Husted S, Katus HA, Maurer G, Lopez-Sendon J , Steg PG et al (2015) GDF-15 at One Month After an Acute Coronary Syndrome is Associated With Increased Risk of Major Bleeding - A PLATO Biomarker Substudy. CIRCULATION, Vol. 132 RIS download Bibtex download
  • Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Kuder J, Murphy SA, Magnani G , Budaj A et al (2015) Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54. CIRCULATION, Vol. 132 RIS download Bibtex download
  • Murphy SA, Bonaca MP, Goto S, Bhatt DL, Steg PG, Storey RF, Deenadayalu N, Kuder JF, Magnani G, Theroux P , Nicolau JC et al (2015) Reduction in Total Cardiovascular Events With Long-term Use of Ticagrelor in Patients With Prior Myocardial Infarction in the PEGASUS-TIMI 54 Trial. CIRCULATION, Vol. 132 RIS download Bibtex download
  • Bonaca MP, Bhatt DL, Steg PG, Budaj A, Bansilal S, Storey RF, Im K, Magnani G, Ophuis TO, Ruda M , Hamm C et al (2015) TCT-78 Efficacy of Long-Term Ticagrelor in Stented Patients in PEGASUS-TIMI 54. Journal of the American College of Cardiology, Vol. 66(15) (pp B36-B36) RIS download Bibtex download
  • Magnani G, Sabatine MS, Bhatt DL, Choen M, Steg G, Storey R, Kuder J, Murphy S, Braunwald E & Bonaca MP (2015) Efficacy and Safety of Ticagrelor for Long-Term Secondary Prevention of Atherothrombotic Events in Relation to Renal Function: Insights from the PEGASUS-TIMI 54 trial. EUROPEAN HEART JOURNAL, Vol. 36 (pp 520-520) RIS download Bibtex download
  • Cayla G, Lapostolle F, Hammett CJ, Merkely B, Lassen JF, Storey RF, Ten Berg JM, Hamm CW, Van 'T Hof AW & Montalescot G (2015) Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: the French subgroup analysis of the ATLANTIC study. EUROPEAN HEART JOURNAL, Vol. 36 (pp 68-68) RIS download Bibtex download
  • Ducrocq G, Schulte PJ, Budaj A, Cornel JH, Held C, Himmelmann A, Husted S, Storey RF, Wallentin L, Steg PG & Investigators PLATOT (2015) Balancing the risk of ischaemic and bleeding events in ACS. EUROPEAN HEART JOURNAL, Vol. 36 (pp 860-861) RIS download Bibtex download
  • Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Bhatt DL, Steg PG, Ahsan AJ, Kuder J, Braunwald E & Sabatine MS (2015) Ticagrelor 60 mg twice-daily provides effective platelet inhibition in patients with prior myocardial infarction: the PEGASUS-TIMI 54 platelet function substudy. EUROPEAN HEART JOURNAL, Vol. 36 (pp 549-549) RIS download Bibtex download
  • O'Donoghue ML, Bonaca MP, Magnani G, Bhatt DL, Cohen M, Steg PG, Storey RF, Murphy SM, Braunwald E & Sabatine MS (2015) The efficacy and safety of ticagrelor in women versus men with a prior myocardial infarction: insights from the PEGASUS-TIMI 54 trial. EUROPEAN HEART JOURNAL, Vol. 36 (pp 549-549) RIS download Bibtex download
  • Kaudewitz D, Skroblin P, Willeit K, Willeit P, Barwari T, Zampetaki A, Morton AC, Kiechl S, Storey RF & Mayr M (2015) Associations of plasma microRNAs with platelet proteins and platelet function. EUROPEAN HEART JOURNAL, Vol. 36 (pp 230-230) RIS download Bibtex download
  • Thomas M, Ajjan R, Phoenix F, Outteridge S, Dockrell D, Sabroe I & Storey R (2015) 203 Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia. Heart, Vol. 101(Suppl 4) (pp A112.1-A112) RIS download Bibtex download
  • Silvain J, Storey R, Cayla G, Esteve J-B, Dillinger J-G, Vicaut E, Collet J-P, Tsatsaris A, Licour M, Salhi N , Lapostolle F et al (2015) IMPACT OF MORPHINE ADMINISTRATION ON TICAGRELOR-INDUCED PLATELET INHIBITION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED BY PRIMARY PCI: RESULTS FROM THE PRIVATE-ATLANTIC STUDY. Journal of the American College of Cardiology, Vol. 65(10) (pp A15-A15) RIS download Bibtex download
  • Silvain J, Storey R, Cayla G, Esteve J-B, Dillinger J-G, Vicat E, Collet J-P, Tsatsaris A, Baradat C, Salhi N , Lapostolle F et al (2015) P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY. Journal of the American College of Cardiology, Vol. 65(10) (pp A221-A221) RIS download Bibtex download
  • Andell P, James S, Cannon C, Cyr D, Himmelmann A, Husted S, Keltai M, Koul S, Santoso A, Steg P , Storey R et al (2015) TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 65(10) (pp A114-A114) RIS download Bibtex download
  • Wallentin L, Michelsen AE, Aukrust P, Becker R, Bertilsson M, Budaj A, Cornel J, Himmelmann A, Husted S, Siegbahn A , Storey R et al (2015) ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) AND OUTCOMES IN ACUTE CORONARY SYNDROMES: A PLATO BIOMARKER SUBSTUDY. Journal of the American College of Cardiology, Vol. 65(10) (pp A231-A231) RIS download Bibtex download
  • Thomas MR, Alsharif KF, Prince LR, Ridger VC, Judge HM, Dockrell DH, Sabroe I & Storey RF (2015) TICAGRELOR POTENTIATES NEUTROPHIL PHAGOCYTOSIS VIA INHIBITION OF ADENOSINE REUPTAKE BY ERYTHROCYTES. Journal of the American College of Cardiology, Vol. 65(10) (pp A259-A259) RIS download Bibtex download
  • Thomas MR, Ajjan RA, Phoenix F, Outteridge SN, Dockrell DH, Sabroe I & Storey RF (2015) TICAGRELOR INHIBITS CHANGES IN FIBRIN CLOT STRUCTURE INDUCED BY BACTERIAL ENDOTOXEMIA. Journal of the American College of Cardiology, Vol. 65(10) (pp A12-A12) RIS download Bibtex download
  • Bender L, Mayr M, Kaudewitz D, Skroblin P, Willeit P, Morton A, Gracio F, Dudek K, Langley S, Kiechl S , Warner T et al (2014) Plasma microRNA levels in patients with acute coronary syndrome are associated with platelet function. Atherosclerosis, Vol. 237(2) (pp e5-e5) RIS download Bibtex download
  • Iqbal J, Rowe R, Zhang Y-J, Parviz Y, Morton AC, Grech E, Gunn JP & Storey RF (2014) Lower Mortality and Stent Thrombosis Rates Associated With Introduction of Potent P2Y12 Inhibitors in Patients With Acute Coronary Syndromes. CIRCULATION, Vol. 130 RIS download Bibtex download
  • Mayr M, Kaudewitz D, Skroblin P, Willeit P, Zampetaki A, Morton AC & Storey RF (2014) Plasma MicroRNAs Correlate With Platelet Reactivity in Patients With Acute Coronary Syndrome: Association With Platelet Function. CIRCULATION, Vol. 130 RIS download Bibtex download
  • Ueland T, Aukrust P, Michelsen A, Bertilsson M, James SK, Himmelmann A, Siegbahn A, Storey R, Kontny F, Wallentin L & PLATO (2014) Secreted wingless (Wnt) antagonists and risk prediction in acute coronary syndrome (ACS) a PLATO biomarker substudy. EUROPEAN HEART JOURNAL, Vol. 35 (pp 318-318) RIS download Bibtex download
  • Oskarsson A, Varenhorst C, Hagstrom E, Wernroth ML, Becker RC, Held C, Himmelmann A, Storey RF, Wallentin L, James S & Investigators PLATO (2014) ApoA1 is independently associated with recurrent ischemic events and death in acute coronary syndrome patients. EUROPEAN HEART JOURNAL, Vol. 35 (pp 482-482) RIS download Bibtex download
  • Ueland T, Michelsen A, Aukrust P, Becker R, Bertilsson M, James SK, Siegbahn A, Storey RF, Wallentin L, Kontny F & PLATO (2014) Chemokine (CXC motif) ligand 16 (CXCL16) and osteoprotegerin (OPG) as predictors of outcome in patients with acute coronary syndromes (ACS) a PLATO biomarker substudy. EUROPEAN HEART JOURNAL, Vol. 35 (pp 486-486) RIS download Bibtex download
  • Thomas MR, Outteridge SN, Ecob R, Sangha GK, Faulkner RE, West LE, Judge HM, Dockrell DH, Sabroe I & Storey RF (2014) Ticagrelor inhibits release of pro-inflammatory cytokines TNF and IL-6 during human endotoxaemia. European Heart Journal, Vol. 35(Supp1) (pp 1170-1170), 30 August 2014 - 3 September 2014. RIS download Bibtex download
  • Alsharif K, Judge H, Ridger V & Storey RF (2014) Ticagrelor and dipyridamole potentiate adenosine-induced stimulation of neutrophil chemotaxis in the presence of erythrocytes. EUROPEAN HEART JOURNAL, Vol. 35 (pp 1031-1032) RIS download Bibtex download
  • Varenhorst C, Eriksson N, Johansson Å, Barratt B, Åkerblom A, Hagström E, Syvänen A-C, Becker R, James S, Katus H , Husted S et al (2014) TICAGRELOR PLASMA LEVELS BUT NOT CLINICAL OUTCOMES ARE ASSOCIATED WITH TRANSPORTER AND METABOLISM ENZYME GENETIC POLYMORPHISMS. Journal of the American College of Cardiology, Vol. 63(12) (pp A25-A25) RIS download Bibtex download
  • Bui A, Cannon C, Steg P, Storey R, Husted S, Ren F, James S, Michelson E, Himmelmann A, Wallentin L & Scirica B (2014) RISK OF CARDIOVASCULAR DEATH AND NON-SUSTAINED VENTRICULAR TACHYCARDIA DETECTED 30-DAYS AFTER ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL. Journal of the American College of Cardiology, Vol. 63(12) (pp A298-A298) RIS download Bibtex download
  • Velders M, Wallentin L, Becker R, van Boven AJ, Himmelmann A, Husted S, Lindholm D, Morais J, Siegbahn A, Storey R , Wernroth L et al (2014) ROLE OF ADMISSION CARDIAC BIOMARKERS IN RISK STRATIFICATION OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES TRIAL. Journal of the American College of Cardiology, Vol. 63(12) (pp A18-A18) RIS download Bibtex download
  • Akerblom A, Wallentin L, Siegbahn A, Becker RC, Budaj A, Himmelmann A, Husted S, Storey RF, Eriksson N, Johansson A & James SK (2013) Genetic Polymorphism and Relationship to Cystatin C Concentrations and Outcome - Results From the Platelet Inhibition and Patient Outcomes Study. CIRCULATION, Vol. 128(22) RIS download Bibtex download
  • Tricoci P, Chen E, Neely ML, Warner A, Wong PH, Sinnaeve P, Wallentin L, Jennings LK, Storey RF, Aylward PE , White HD et al (2013) CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION, Vol. 128(22) RIS download Bibtex download
  • Hagstrom E, Eriksson N, Johansson A, Bertilsson M, Axelsson T, Barratt BJ, Becker RC, Himmelmann A, James SK, Katus HA , Siegbahn A et al (2013) Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome? - A Report From the Plato Gwas Study. CIRCULATION, Vol. 128(22) RIS download Bibtex download
  • Siegbahn A, Johansson A, Eriksson N, Hagstrom E, Varenhorst C, Akerblom A, Bertilsson M, Axelsson T, Barratt BJ, Becker RC , Himmelmann A et al (2013) Evaluation of the Effect of Interleukin 18 Associated Genetic Polymorphisms on Risk of Cardiovascular Events in Patients With Acute Coronary Syndrome. CIRCULATION, Vol. 128(22) RIS download Bibtex download
  • Morton AC, Hossain R, Ecob R, Walker J, Gunn J, Judge HM & Storey RF (2013) Morphine Delays the Onset of Action of Prasugrel in Patients With Prior History of St Elevation Myocardial Infarction. CIRCULATION, Vol. 128(22) RIS download Bibtex download
  • Kaudewitz D, Lee R, Willeit P, Zampetaki A, Morton AC, Warner TD, Storey RF, Channon K & Mayr M (2013) Impact of Medication on Quantification of Plasma MicroRNAs in Patients With Cardiovascular Disease. CIRCULATION, Vol. 128(22) RIS download Bibtex download
  • Wallentin L, James S, Giannitsis E, Katus H, Becker RC, Cannon CP, Horrow J, Husted S, Siegbahn A, Steg GP , Storey RF et al (2013) Outcomes with ticagrelor versus clopidogrel in relation to high sensitivity troponin-T in non-ST-elevation acute coronary syndrome patients managed with early invasive or non-invasive treatment - a substudy from the prospective randomized PLATelet inhibit. PHARMACOTHERAPY, Vol. 33(10) (pp E189-E189) RIS download Bibtex download
  • Varenhorst C, Alstrom U, Braun OO, Storey RF, Mahaffey KW, Cannon C, Himmelmann A, James S, Wallentin L & Held C (2013) Difference in causes of death between ticagrelor and clopidogrel in the PLATO trial. EUROPEAN HEART JOURNAL, Vol. 34 (pp 827-827) RIS download Bibtex download
  • Hess KA, Kurdee Z, Oxley N, Phoenix F, Marx N, King R, Storey RF, Grant PJ & Ajjan RA (2013) Modulation of complement C3 levels and fibrin clot structure: the role of aspirin dose. EUROPEAN HEART JOURNAL, Vol. 34 (pp 891-891) RIS download Bibtex download
  • Storey RF, Ardissino D, Vignali L, Cairns R, Becker RC, Cannon CP, Himmelmann A, Husted S, James SK & Wallentin L (2013) Ischaemic events following planned discontinuation of study treatment with ticagrelor or clopidogrel in the PLATO study. EUROPEAN HEART JOURNAL, Vol. 34 (pp 826-826) RIS download Bibtex download
  • Wallentin LC, Bertilsson M, Becker RC, Himmelmann A, Husted S, James S, Katus H, Steg G, Storey RF, Siegbahn A & PLATO (2013) GDF-15 level in acute coronary syndrome and its relations to cardiovascular risk factors, disease manifestations, treatments and outcome - results from the PLATO-study. EUROPEAN HEART JOURNAL, Vol. 34 (pp 733-733) RIS download Bibtex download
  • James S, Storey RF, Cannon C, Janzon M, Nicolau JC, Parasuraman B, Mellstrom K, Wallentin L & Henriksson M (2013) Health economic evaluation of ticagrelor compared to generic clopidogrel in patients with acute coronary syndromes intended for non-invasive management based on the PLATO trial. EUROPEAN HEART JOURNAL, Vol. 34 (pp 896-896) RIS download Bibtex download
  • Chow EYK, Iqbal A, Walkinshaw E, Solomon AL, Daly R, Judge HM, Storey RF & Heller SR (2013) Hypoglycemia Increases Platelet Reactivity in Patients With Type 2 Diabetes. DIABETES, Vol. 62 (pp A100-A100) RIS download Bibtex download
  • West L, Francis S & Storey R (2013) YIA6: VESSEL WALL, BUT NOT PLATELET, P2Y12 CONTRIBUTES TO EARLY ATHEROGENESIS. Heart, Vol. 99(suppl 2) (pp A7-A7) RIS download Bibtex download
  • Willeit P, Zampetaki A, Kaudewitz D, Lee R, Dudek K, King A, Kirkby NS, Markus HS, Warner TD, Kiechl S , Morton AC et al (2013) PLASMA MICRORNAS AS BIOMARKERS FOR PLATELET INHIBITION. HEART, Vol. 99 RIS download Bibtex download
  • Bansilal S, Wiviott S, Becker R, Harrington R, Himmelmann A, Neely B, Husted S, Storey R, Steg P, Katus H , James S et al (2013) THE EFFICACY AND SAFETY OF TICAGRELOR AS COMPARED TO CLOPIDOGREL, WITH AND WITHOUT A GLYCOPROTEIN IIB/IIIA INHIBITOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS INTERVENTION: A PLATO (STUDY OF PLATELET INHIBITION AND PATIENT OUTCOMES) ANALYSIS. Journal of the American College of Cardiology, Vol. 61(10) (pp E1858-E1858) RIS download Bibtex download
  • Lindholm D, Varenhorst C, Cannon C, Harrington R, Himmelmann A, Maya J, Husted S, Katus H, Steg P, Storey R , Wallentin L et al (2013) TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO TRIAL. Journal of the American College of Cardiology, Vol. 61(10) (pp E1-E1) RIS download Bibtex download
  • Lee GA, Wyatt S, Topliss D, Walker KZ & Storey R (2013) A study of a preoperative intervention in patients with diabetes undergoing cardiac surgery. DIABETIC MEDICINE, Vol. 30 (pp 152-152) RIS download Bibtex download
  • Bright RJ, Storey RF & Chico TJ (2012) ZEBRAFISH AS A MODEL TO INVESTIGATE THE ROLES OF THE P2Y12 RECEPTOR IN VIVO. ATHEROSCLEROSIS, Vol. 225(2) (pp E1-E1) RIS download Bibtex download
  • Sinnaeve PR, Bueno H, Danchin N, Sanchez-Covisa J, Licour M, Annemans L, Jukema JW, Storey RF, Van de Werf F & Zeymer U (2012) Contemporary pre-hospital management of ACS patients: results from the EPICOR study. EUROPEAN HEART JOURNAL, Vol. 33 (pp 314-314) RIS download Bibtex download
  • Akerblom A, Wallentin L, Siegbahn A, Becker RC, Budaj A, Katus H, Claeys MJ, Storey RF, Asenblad N, James SK & Outcom PIP (2012) Serial cystatin C measurements and changes in glomerular filtration rate as predictors for death or myocardial infarction in ACS patients. EUROPEAN HEART JOURNAL, Vol. 33 (pp 135-135) RIS download Bibtex download
  • Sinnaeve PR, Bueno H, Danchin N, Sanchez-Covisa J, Licour M, Annemans L, Jukema JW, Storey RF, Zeymer U & Van De Werf F (2012) Availability of cath lab facilities and contemporary inter-hospital transfer patterns for the management of ACS patients: findings from the EPICOR study. EUROPEAN HEART JOURNAL, Vol. 33 (pp 145-145) RIS download Bibtex download
  • Bueno H, Storey RF, Danchin N, Sanchez-Covisa J, Sazova O, Licour M, Annemans L, Jukema JW, Zeymer U & Van de Werf F (2012) Current regional differences in the use of antiplatelet drugs for the treatment of acute coronary syndromes. Results from the EPICOR study. EUROPEAN HEART JOURNAL, Vol. 33 (pp 311-311) RIS download Bibtex download
  • Tricoci P, Whellan DJ, Vranckx P, Leibovitz D, Huang Z, Strony J, Nicolau J, Storey RF, Chen E & Mahaffey K (2012) Vorapaxar in ACS patients undergoing CABG surgery: results from the TRACER trial. EUROPEAN HEART JOURNAL, Vol. 33 (pp 508-509) RIS download Bibtex download
  • Wallentin L, James S, Storey R, Barratt B, Horrow J, Husted S, Katus H, Steg P & Becker R (2012) GREATER EFFICACY OF TICAGRELOR COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME IS NOT DRIVEN BY OUTCOMES IN POOR METABOLIZERS OF CLOPIDOGREL. Journal of the American College of Cardiology, Vol. 59(13) (pp E500-E500) RIS download Bibtex download
  • Cornel JH, Becker R, Goodman S, Husted S, Katus H, Santoso A, Steg P, Storey R, Vintila M, sun J , Horrow J et al (2012) PRIOR SMOKING STATUS, CLINICAL OUTCOMES, AND THE COMPARISON OF TICAGRELOR WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROMES – INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 59(13) (pp E495-E495) RIS download Bibtex download
  • Jennings LK, Moliterno D, Storey R, Hord E, Kotha J, Becker R, Smyth S, Providencia L, Moccetti T, Valgimigli M , Dery J-P et al (2012) PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL. Journal of the American College of Cardiology, Vol. 59(13) (pp E351-E351) RIS download Bibtex download
  • Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Storey R, James S & Cannon C (2012) REDUCTION IN FIRST AND RECURRENT CARDIOVASCULAR AND ISCHEMIC EVENTS WITH TICAGRELOR COMPARED WITH CLOPIDOGREL IN THE PLATO STUDY. Journal of the American College of Cardiology, Vol. 59(13) (pp E504-E504) RIS download Bibtex download
  • Wallentin L, James S, Giannitsis E, Katus H, Becker R, Cannon C, cornel J, Emanuelsson HAK, Husted S, Harrington R , Steg P et al (2012) USEFULNESS OF BIOMARKERS FOR PROGNOSTICATION OF OUTCOME WITH EARLY INVASIVE OR NONINVASIVE TREATMENT IN NON-ST-ELEVATION ACUTE CORONARY SYNDROMES – A SUBSTUDY FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 59(13) (pp E497-E497) RIS download Bibtex download
  • Bui AH, Cannon C, Steg P, Storey R, Husted S, Ren F, James S, Michelson E, Horrow J, Wallentin L & Scirica B (2012) RELATIONSHIP BETWEEN NONSUSTAINED VENTRICULAR TACHYCARDIA AND VASCULAR DEATH IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL. Journal of the American College of Cardiology, Vol. 59(13) (pp E629-E629) RIS download Bibtex download
  • Husted S, James S, Becker R, Horrow J, Katus H, Storey R, Cannon C, Heras M, Lopes R, Morais J , Mahaffey K et al (2012) TICAGRELOR VERSUS CLOPIDOGREL IN WOMEN WITH ACUTE CORONARY SYNDROMES – A SUBSTUDY FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 59(13) (pp E507-E507) RIS download Bibtex download
  • Storey RF, Steg P, James S, Husted S, Cannon C, Becker R, Ycas J, Asenblad N, Kilhamn J & Wallentin L (2012) REDUCTION IN PULMONARY ADVERSE EVENTS AND ASSOCIATED SEPSIS AND MORTALITY IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH TICAGRELOR COMPARED TO CLOPIDOGREL: A POST HOC ANALYSIS OF THE PLATO STUDY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 59(13) (pp E482-E482) RIS download Bibtex download
  • Storey RF, James S, Asenblad N, Siegbahn A, Emanuelsson H, Katus H, Cannon C, Husted S, Steg P & Wallentin L (2012) CONSISTENT BENEFIT OF TICAGRELOR COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS REGARDLESS OF BASELINE INFLAMMATORY MARKERS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 59(13) (pp E505-E505) RIS download Bibtex download
  • Karunakaran A, Judge H, Morton A, Milano A, Arnold J, Chico TJ, Flaherty L, Baker D, Daly R & Storey RF (2011) Cytochrome P450 2C19 Loss-Of-Function Genetic Variants but not Paraoxonase-1 Activity Modulate P2Y12 Blockade in Response to Clopidogrel Therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 58(20) (pp B45-B45) RIS download Bibtex download
  • Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J , Mahaffey KW et al (2011) TICAGRELOR VERSUS CLOPIDOGREL IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROMES: A SUBANALYSIS FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 57(14) (pp E1099-E1099) RIS download Bibtex download
  • Åkerblom A, Wallentin L, Siegbahn A, Becker RC, Budaj A, Buck K, Horrow J, Husted S, Katus H, Steg PG , Storey RF et al (2011) CYSTATIN C IS AN INDEPENDENT RISK PREDICTOR FOR DEATH OR MYOCARDIAL INFARCTION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) AS WELL AS IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME (NSTE-ACS). Journal of the American College of Cardiology, Vol. 57(14) (pp E999-E999) RIS download Bibtex download
  • Kunadian V, Zorkun C, James S, Wu J, Muhammad A, Storey R, Steg PG, Katus H, Emanuelsson H, Horrow J , Maya J et al (2011) ANGIOGRAPHIC OUTCOMES IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology, Vol. 57(14) (pp E946-E946) RIS download Bibtex download
  • Goodman SG, Clare R, Pieper KS, James SK, Nicolau JC, Storey RF, Cantor WJ, Angiolillo DJ, Husted S, Cannon CP , Steg PG et al (2010) Proton Pump Inhibitor Use is Likely a Marker for, Rather than a Cause of, a Higher Risk of Cardiovascular Events: Insights from PLATO. CIRCULATION, Vol. 122(21) RIS download Bibtex download
  • Pandya A, Ermolina I, Storey R & Smith G (2010) Relationship between ATP hydrolysis and molecular dynamics in co-freeze-dried sugar-ATP mixtures. JOURNAL OF PHARMACY AND PHARMACOLOGY, Vol. 62(10) (pp 1465-1467) RIS download Bibtex download
  • Storey RF, Bliden KP, Patil SB, Karunakaran A, Ecob R, Butler K, Wei C, Tantry U & Gurbel PA (2010) Earlier recovery of platelet function after treatment cessation in ticagrelor-treated patients compared to clopidogrel high responders. EUROPEAN HEART JOURNAL, Vol. 31 (pp 389-389) RIS download Bibtex download
  • Patil SB, Angiolillo DJ, Desai B, Ecob R, Husted S, Emanuelsson H, Cannon CP, Becker RC, Wallentin L & Storey RF (2010) Platelet inhibition by ticagrelor is not affected by proton pump inhibitors: results from the PLATO PLATELET substudy. EUROPEAN HEART JOURNAL, Vol. 31 (pp 905-906) RIS download Bibtex download
  • James S, Angiolillo DJ, Becker RC, Cornel JH, Horrow J, Husted S, Katus H, Nicolau JC, Storey RF & Wallentin L (2010) Ticagrelor versus clopidogrel in patients with acute coronary syndromes and diabetes in the PLATO trial. EUROPEAN HEART JOURNAL, Vol. 31 (pp 202-202) RIS download Bibtex download
  • Storey RF, Becker RC, Harrington RA, Cannon CP, Husted S, James SK, Cools F, Steg PG, Khurmi N & Wallentin L (2010) Increased incidence of dyspnoea associated with ticagrelor did not appear to adversely affect cardiovascular outcomes in the PLATO study. EUROPEAN HEART JOURNAL, Vol. 31 (pp 203-203) RIS download Bibtex download
  • James S, Roe MT, Cannon CP, Raev D, Horrow J, Husted S, Kontny F, Storey RF, Wallentin L & Harrington R (2010) Ticagrelor versus clopidogrel in patients with Acute Coronary Syndromes intended for a non-invasive management in the PLATO trial. EUROPEAN HEART JOURNAL, Vol. 31 (pp 203-203) RIS download Bibtex download
  • Storey RF, Bliden K, Patil SB, Karunakaran A, Ecob R, Butler K, Teng RL & Gurbel P (2009) The Effect of Ticagrelor on Cardiopulmonary Function in Patients With Stable Coronary Artery Disease. CIRCULATION, Vol. 120(18) (pp S1145-S1145) RIS download Bibtex download
  • Gurbel P, Bliden K, Antonino M, Butler K, Teng RL, Rasmussen L, Storey RF, Nielsen T, Eikelboom J, Sabe-Affaki G , Husted S et al (2009) The Effect of Ticagrelor in Stable Coronary Artery Disease Patients Nonresponsive to Clopidogrel: The RESPOND Study. CIRCULATION, Vol. 120(18) (pp S1173-S1173) RIS download Bibtex download
  • Storey RF, Angiolillo DJ, Patil SB, Desai B, Husted S, Emanuelsson H & Wallentin L (2009) Maintenance Treatment With Ticagrelor Yields Greater and More Consistent Inhibition of Platelet Function Compared to Clopidogrel in Patients With Acute Coronary Syndromes: Results From the PLATO PLATELET Substudy. CIRCULATION, Vol. 120(18) (pp S1027-S1027) RIS download Bibtex download
  • Husted SE, Gurbel P, Storey RF, Bliden K, Hoimark L, Antonino MJ, Mahla E, Tantry U, Butler K, Wei C & Teng RL (2009) Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Coronary Artery Disease. CIRCULATION, Vol. 120(18) (pp S1102-S1102) RIS download Bibtex download
  • Storey RF, Patil SB, Ecob R, Angiolillo DJ & Wallentin L (2009) More Rapid and Consistent Inhibition of Platelet Aggregation is Achieved by Loading With Ticagrelor Compared to Clopidogrel in Patients With Acute Coronary Syndromes: Results From the PLATO PLATELET Substudy. CIRCULATION, Vol. 120(18) (pp S1102-S1102) RIS download Bibtex download
  • Gurbel P, Bliden K, Butler K, Tantry U, Teng RL, Antonino M, Patil SB, Karunakaran A, Kereiakes D, Paris C , Purdy D et al (2009) A Randomized Double-Blind Study to Assess the Onset and Offset of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in Patients With Stable Coronary Artery Disease. CIRCULATION, Vol. 120(18) (pp S1143-S1143) RIS download Bibtex download
  • Cannon CP, Becker R, Emanuelsson H, Harrington R, Horrow J, Husted S, Katus H, Steg PG, Storey RF & Wallentin L (2009) PLATO-Invasive: Comparison of Ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes with a planned invasive strategy: Results of the PLATelet inhibition and patient Outcomes (PLATO) trial. AMERICAN JOURNAL OF CARDIOLOGY, Vol. 104(6A) (pp XVIII-XVIII) RIS download Bibtex download
  • Patil SBG, Judge HM, Buckland RJ & Storey RF (2009) RIFAMPICIN INCREASES THE EXTENT OF P2Y12 RECEPTOR BLOCKADE ACHIEVED BY CLOPIDOGREL ADMINISTRATION. HEART, Vol. 95 (pp A51-A52) RIS download Bibtex download
  • Pandya A, Ermolina I, Storey R & Smith G (2009) High-performance liquid chromatography method development for studying the degradation of freeze-dried adenosine triphosphate when stored at 4 and 40 degrees C. JOURNAL OF PHARMACY AND PHARMACOLOGY, Vol. 61 (pp A130-A130) RIS download Bibtex download
  • Storey RF (2008) New developments in antiplatelet therapy. EUROPEAN HEART JOURNAL SUPPLEMENTS, Vol. 10(D) (pp D30-D37) RIS download Bibtex download
  • Evans DJW, Crosdale DJ, Judge HM, Chamberlain J, Jetha K, Norman KE, Francis SE & Storey RF (2008) The platelet P2Y12 receptor influences the vessel wall response to arterial injury and thrombosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 51(10) (pp A291-A291) RIS download Bibtex download
  • Storey RF (2008) Variability of response to antiplatelet therapy. EUROPEAN HEART JOURNAL SUPPLEMENTS, Vol. 10(A) (pp A21-A27) RIS download Bibtex download
  • Smith SMG, Buckland R, Daly ME & Storey RF (2007) Inhibition of platelet aggregation by clopiclogrel is unaffected by the CYP2C19 681G > A polyrnorphism in patients with coronary artery disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 49(9) (pp 375A-375A) RIS download Bibtex download
  • Storey RF, Cannon CP, Harrington RA, Sandset PM, Helptinstall S, Wickens M, Peters G, Emanuelsson H, Price D & Husted S (2006) AZD6140 exerts greater inhibition of platelet aggregation than clopidogrel in patients with stable atherosclerotic disease or unstable coronary disease. CIRCULATION, Vol. 114(18) (pp 698-699) RIS download Bibtex download
  • Husted S, Harrington RA, Cannon CP, Storey RF, Wickens M, Price D & Emanuelsson H (2006) AZD6140, a reversible oral ADP receptor antagonist, does not increase risk of bleeding vs the thienopyridine clopidogrel in patients undergoing CABG surgery in the DISPERSE2 trial. AMERICAN JOURNAL OF CARDIOLOGY, Vol. 98(8A) (pp 204M-204M) RIS download Bibtex download
  • Smith SMG, Judge HM, Daly ME & Storey RF (2006) The G allele of the platelet P2Y1 1622 A > G polymorphism is not associated with platelet hyper-reactivity to ADP in either healthy volunteers or CAD patients. EUROPEAN HEART JOURNAL, Vol. 27 (pp 756-756) RIS download Bibtex download
  • Evans D, Crosdale DJ, Norman KE, Francis SE & Storey RF (2006) The P2Y12 receptor regulates the vessel wall response to arterial injury and thrombosis. EUROPEAN HEART JOURNAL, Vol. 27 (pp 753-753) RIS download Bibtex download
  • Evans D, Crosdale D, Norman K, Francis S & Storey R (2006) The P2Y12 receptor regulates the vessel wall response to arterial injury and thrombosis. HEART, Vol. 92 (pp A111-A111) RIS download Bibtex download
  • Smith S, Judge H, Daly M & Storey R (2006) Platelet protease-activated receptor 1 density, trap-induced platelet responses, and the effect of complete P2Y(12) receptor blockade. HEART, Vol. 92 (pp A111-A112) RIS download Bibtex download
  • Cannon CP, Harrington RA, Mahaffey KW, Husted S, Storey RF, Sanders N, Peters G & Emanuelsson H (2006) Clinical outcomes with AZD6140, an oral reversible ADP receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes (ACS). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 199A-200A) RIS download Bibtex download
  • Emanuelsson H, Mahaffey KW, Harrington RA, Husted S, Storey RF, Sanders N, Peters G & Cannon CP (2006) Greater inhibition of platelet aggregation be tolerated? - Evaluation of the bleeding risk of AZD6140 compared with clopidogrel (CLOP) in patients with acute coronary syndromes (ACS). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 212A-212A) RIS download Bibtex download
  • Husted S, Storey RF, Harrington RA, Sanders N, Peters G, Emanuelsson H & Cannon CP (2006) The effects of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel on biochemical markers in patients with acute coronary syndromes (ACS). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 200A-200A) RIS download Bibtex download
  • Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Gurbel PA, Grande P, Sanders N, Peters G, Emanuelsson H & Cannon CP (2006) AZD6140 yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 204A-204A) RIS download Bibtex download
  • Storey RF, Harrington RA, Husted S, Heptinstall S, Wilcox RG, Gurbel PA, Grande P, Sanders N, Peters G, Emanuelsson H & Cannon CP (2006) AZD6140 yields additional suppression of platelet aggregation in patients with acute coronary syndromes previously treated with clopidogrel. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 204A-204A) RIS download Bibtex download
  • Cannon CP, Husted S, Storey RF, Harrington RA, Hill S, Price D, Sanders N, Emanuelsson H, Peters G & DISPERSE 2 Investigators (2005) The DISPERSE2 trial: Safety, tolerability and preliminary efficacy of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel in patients with non-ST segment elevation acute coronary syndrome. CIRCULATION, Vol. 112(17) (pp U677-U677) RIS download Bibtex download
  • Smith SMG, Judge HM, Peters G, Armstrong M, Fontana P, Gaussem P & Storey RF (2005) Common sequence variations in the P2Y12 and CYP3A5 genes do not explain variability in the inhibitory effects of clopidogrel therapy. EUROPEAN HEART JOURNAL, Vol. 26 (pp 486-486) RIS download Bibtex download
  • Judge H, Buckland R, Crosdale D & Storey RF (2005) Partial P2Y12 receptor blockade by clopidogrel may not be overcome by increasing the clopidogrel dose. EUROPEAN HEART JOURNAL, Vol. 26 (pp 487-487) RIS download Bibtex download
  • Shrivastava V, Akowuah E, Jamnadas B, Storey R, Matuszewski M, Pradeep S, Hopkinson DN, Braidley PC & Cooper GJ (2004) A randomized double blind comparison of two strategies for managing patients on aspirin and clopidogrel therapy requiring urgent coronary revascularization. CIRCULATION, Vol. 110(17) (pp 356-356) RIS download Bibtex download
  • Smith SMG, Judge HM, Peters G, Armstrong M, Fontana P, Gaussem P & Storey RF (2004) Gene sequence variations influence platelet reactivity before and during clopidogrel therapy. EUROPEAN HEART JOURNAL, Vol. 25 (pp 237-237) RIS download Bibtex download
  • Smith SMG, Judge HM, Peters G & Storey RF (2004) Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention. HEART, Vol. 90 (pp A31-A31) RIS download Bibtex download
  • Behan MWH, Fox SC, Storey RF & Heptinstall S (2003) Effects of clopidogrel on platelet calcium mobilisation in acute coronary syndrome patients. EUROPEAN HEART JOURNAL, Vol. 24 (pp 323-323) RIS download Bibtex download
  • Behan MW, Fox S, Sanderson H & Storey R (2002) Effect of clopidogrel on procoagulant activity in acute coronary syndromes: Evidence for incomplete P2Y12 receptor blockade. CIRCULATION, Vol. 106(19) (pp 149-150) RIS download Bibtex download
  • Storey RF, Judge HM, Wilcox RG & Heptinstall S (2002) Inhibition of ADP-induced platelet-leukocyte conjugate formation by clopidogrel and AR-C69931MX. EUROPEAN HEART JOURNAL, Vol. 23 (pp 722-722) RIS download Bibtex download
  • Storey RF (2001) Clinical experience with antithrombotic drugs acting on purine receptor pathways. DRUG DEVELOPMENT RESEARCH, Vol. 52(1-2) (pp 202-212) RIS download Bibtex download

Other

Research group

PhD Students

  • Dr William Parker
  • Dr Wael Sumaya

MD Students

  • Dr Rachel Orme
  • Dr Vatchsala Sree Varadharajan
Teaching activities

I am currently coordinator for the first year medical undergraduate Cardiovascular System module.

Professional activities
  • 2019: Research of the Year award, British Cardiovascular Intervention Society.
  • 2017: Member of the BHF Fellowships Committee.
  • 2015-2019: Member of the NIHR EME board.
  • 2000: DM with distinction, 'Novel platelet antagonists in the management of ischaemic heart disease', University of Nottingham.
  • 1999: Young Investigators Award, International Society of Thrombosis and Haemostasis.